Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Capital Expenditures: 2016-2025

Historic Capital Expenditures for Anaptysbio (ANAB) over the last 10 years, with Sep 2025 value amounting to $12,000.

  • Anaptysbio's Capital Expenditures fell 65.71% to $12,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $349,000, marking a year-over-year decrease of 6.93%. This contributed to the annual value of $358,000 for FY2024, which is 55.64% down from last year.
  • Anaptysbio's Capital Expenditures amounted to $12,000 in Q3 2025, which was down 69.23% from $39,000 recorded in Q2 2025.
  • Anaptysbio's Capital Expenditures' 5-year high stood at $863,000 during Q2 2021, with a 5-year trough of $12,000 in Q3 2025.
  • In the last 3 years, Anaptysbio's Capital Expenditures had a median value of $39,000 in 2025 and averaged $113,727.
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 95.50% in 2021, then spiked by 1,150.00% in 2022.
  • Over the past 5 years, Anaptysbio's Capital Expenditures (Quarterly) stood at $14,000 in 2021, then skyrocketed by 1,150.00% to $175,000 in 2022, then soared by 60.00% to $280,000 in 2023, then fell by 6.07% to $263,000 in 2024, then crashed by 65.71% to $12,000 in 2025.
  • Its Capital Expenditures was $12,000 in Q3 2025, compared to $39,000 in Q2 2025 and $35,000 in Q1 2025.